JUL 19, 2018 10:21 AM PDT

Stopping Structural Changes in Collagen may Prevent Lung Fibrosis

WRITTEN BY: Carmen Leitch

Lung fibrosis is a serious condition that thickens tissues in the lungs and makes it hard to breathe. It can be caused by a variety of environmental factors, including exposure to coal or grain dust. New work has shown that it may be possible to prevent the disease with a drug that can block structural changes to collagen. It has been suggested that it is not the amount, but rather the structure of collagen that can lead to lung fibrosis. This research, reported in eLife, has also revealed how drugs can protect against those changes. 

The architecture of our tissues is called the  extracellular matrix (ECM) and it had been thought that when that ECM accumulates, tissues get stiff and fibrosis can happen. Recent work has suggested, however, that the increase in stiffness causes more ECM material to build up, feeding a cycle that is constantly generating new scar tissue.

"We knew that stiffness is an important factor in the build-up of scar tissue in the lung," explained the lead author of this study, Mark Jones, NIHR Clinical Lecturer in Respiratory Medicine at the NIHR Southampton Biomedical Research Centre and University of Southampton, UK. "But we didn't understand what specifically causes increased stiffness in diseased human tissue. Given that excessive build-up of collagen is considered a hallmark of fibrosis, we wanted to see whether this molecule has a role in tissue stiffness."

The research team began by assessing lung tissue taken from healthy people and those with lung fibrosis to learn more about the biological and structural changes the disorder causes in that organ. The lung samples taken from fibrosis patients turned out to be far stiffer than what was taken from healthy people, but the levels of collagen were startlingly similar.
 
Next, the scientists analyzed enzymes that help crosslink collagen, which imparts its unique structure. The LOXL family is one such group of these enzymes; they were found at much higher levels in the fibrosis lung samples. 

Digging deeper, the researchers looked at collagen structure within the fibrosis samples, finding that stiffness was present wherever so-called mature cross-linked collagen levels were high. The collagen building block, called fibril, was also found to be altered in these samples. This work suggests that tissue stiffness is determined by collagen structure, which is regulated by he LOXL family.

A movie demonstrating how the effect of different treatments on tissue stiffness can be tested using patient cells which have been grown in 3D.

Knowing that, the team wanted to see if they could change collagen structure with the LOXL enzymes, and whether that could prevent lung fibrosis. LOXL-2 and LOXL-3 are blocked by an enzyme, PXS-S2A in lung cells harvested from fibrosis patients. Exposure to that drug reduced the level of cross-linked molecules in those cells. It also lowered stiffness, even at low drug concentrations. When applied to a rat model of lung fibrosis, treated rats showed no adverse impacts and had improvement in lung function and reduced fibrosis.

"Together, our results identify that treatment approaches which maintain normal collagen architecture may prevent tissue stiffening and limit the mechanisms that drive progressive fibrosis," noted Donna Davies, Professor of Respiratory Cell and Molecular Biology at the University of Southampton. "Our findings suggest the need to conduct studies in patients with lung fibrosis to see whether these approaches would be of benefit."


Sorces: AAAS/Eurekalert!, Mayo CliniceLife

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUN 08, 2021
Neuroscience
Simple Blood Test Can Detect Depression and Underlying Neurodegeneration
JUN 08, 2021
Simple Blood Test Can Detect Depression and Underlying Neurodegeneration
Researchers led by King’s College London have found that levels of a protein known as neurofilament light chain (N ...
JUN 17, 2021
Microbiology
Malaria Pathogen Caught Invading Red Blood Cells
JUN 17, 2021
Malaria Pathogen Caught Invading Red Blood Cells
Mosquitoes are the world's deadliest animals (after humans) and they transmit malaria, which kills about 400,000 people ...
JUL 05, 2021
Health & Medicine
No Rise in Acid-Related Diseases After Reduction of PPI Use
JUL 05, 2021
No Rise in Acid-Related Diseases After Reduction of PPI Use
In a study including several million veterans as participants, researchers at the University of Michigan found that an i ...
JUL 11, 2021
Drug Discovery & Development
Could Mucus-Based Drugs Replace Antibiotics?
JUL 11, 2021
Could Mucus-Based Drugs Replace Antibiotics?
Researchers from the Copenhagen Center for Glycomics in Denmark have developed a way to produce healthy mucus artificial ...
JUL 16, 2021
Coronavirus
Focusing on the Cause of Neurological Symptoms of COVID-19
JUL 16, 2021
Focusing on the Cause of Neurological Symptoms of COVID-19
We now know that COVID-19 can cause a range of symptoms. Some of these problems are taking months to clear up in patient ...
JUL 27, 2021
Neuroscience
Proportion of Neurotransmitters in the Brain Predict Math Ability
JUL 27, 2021
Proportion of Neurotransmitters in the Brain Predict Math Ability
According to researchers at the University of Oxford in the UK, the proportion of two common neurotransmitters in the br ...
Loading Comments...